ArriVent BioPharma (AVBP) Short Interest Ratio & Short Volume $20.89 -0.88 (-4.04%) Closing price 04:00 PM EasternExtended Trading$19.80 -1.09 (-5.22%) As of 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ArriVent BioPharma Short Interest DataArriVent BioPharma (AVBP) has a short interest of 5.02 million shares, representing 25.85% of the float (the number of shares available for trading by the public). This marks a -12.24% decrease in short interest from the previous month. The short interest ratio (days to cover) is 16.7, indicating that it would take 16.7 days of the average trading volume of 222,151 shares to cover all short positions.Current Short Interest5,020,000 sharesPrevious Short Interest5,720,000 sharesChange Vs. Previous Month-12.24%Dollar Volume Sold Short$116.82 millionShort Interest Ratio16.7 Days to CoverLast Record DateJune 15, 2025Outstanding Shares34,210,000 sharesFloat Size19,420,000 sharesShort Percent of Float25.85%Today's Trading Volume412,799 sharesAverage Trading Volume222,151 sharesToday's Volume Vs. Average186% Short Selling ArriVent BioPharma? Sign up to receive the latest short interest report for ArriVent BioPharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAVBP Short Interest Over TimeAVBP Days to Cover Over TimeAVBP Percentage of Float Shorted Over Time ArriVent BioPharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20255,020,000 shares $116.82 million -12.2%25.9%16.7 $23.27 5/31/20255,720,000 shares $121.26 million +3.6%29.5%23.4 $21.20 5/15/20255,520,000 shares $106.20 million +3.0%28.4%25.5 $19.24 4/30/20255,360,000 shares $113.95 million No Change27.6%26.8 $21.26 4/15/20255,360,000 shares $99.86 million +31.7%27.6%26.4 $18.63 3/31/20254,070,000 shares $75.25 million +10.3%21.0%20.9 $18.49 3/15/20253,690,000 shares $77.49 million -1.1%19.0%21.6 $21.00 2/28/20253,730,000 shares $88.07 million -11.0%19.2%23.4 $23.61 2/15/20254,190,000 shares $111.45 million -3.0%21.8%26.8 $26.60 1/31/20254,320,000 shares $123.29 million +9.1%22.2%27.1 $28.54 Get the Latest News and Ratings for AVBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/20253,960,000 shares $98.68 million +3.9%20.3%25.8 $24.92 12/31/20243,810,000 shares $101.50 million +13.1%19.5%25.5 $26.64 12/15/20243,370,000 shares $90.05 million +1.8%17.3%21.2 $26.72 11/30/20243,310,000 shares $99.17 million +6.1%17.0%13.3 $29.96 11/15/20243,120,000 shares $84.90 million -11.9%16.1%11.3 $27.21 10/31/20243,540,000 shares $103.86 million +3.8%18.3%12.8 $29.34 10/15/20243,410,000 shares $96.88 million +1.8%17.6%13 $28.41 9/30/20243,350,000 shares $78.73 million +80.1%17.3%13.4 $23.50 9/15/20241,860,000 shares $44.19 million +13.4%9.6%7.9 $23.76 8/31/20241,640,000 shares $43.84 million +0.6%8.5%12.4 $26.73 8/15/20241,630,000 shares $38.89 million -2.4%8.4%19.3 $23.86 7/31/20241,670,000 shares $36.57 million +3.1%8.5%28.2 $21.90 7/15/20241,620,000 shares $31.80 million No Change8.2%26.7 $19.63 AVBP Short Interest - Frequently Asked Questions What is ArriVent BioPharma's current short interest? Short interest is the volume of ArriVent BioPharma shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 5,020,000 shares of AVBP short. 25.85% of ArriVent BioPharma's shares are currently sold short. Learn More on ArriVent BioPharma's current short interest. What is a good short interest ratio for ArriVent BioPharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVBP shares currently have a short interest ratio of 17.0. Learn More on ArriVent BioPharma's short interest ratio. What is a good short interest percentage for ArriVent BioPharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 25.85% of ArriVent BioPharma's floating shares are currently sold short. Is ArriVent BioPharma's short interest increasing or decreasing? ArriVent BioPharma saw a drop in short interest during the month of June. As of June 15th, there was short interest totaling 5,020,000 shares, a drop of 12.2% from the previous total of 5,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ArriVent BioPharma's float size? ArriVent BioPharma currently has issued a total of 34,210,000 shares. Some of ArriVent BioPharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ArriVent BioPharma currently has a public float of 19,420,000 shares. How does ArriVent BioPharma's short interest compare to its competitors? 25.85% of ArriVent BioPharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ArriVent BioPharma: Kymera Therapeutics, Inc. (13.86%), Crinetics Pharmaceuticals, Inc. (11.55%), Viking Therapeutics, Inc. (26.43%), MoonLake Immunotherapeutics (11.56%), Alvotech (1.28%), HUTCHMED (China) Limited Sponsored ADR (0.26%), Immunovant, Inc. (29.05%), Catalyst Pharmaceuticals, Inc. (7.07%), Organon & Co. (6.16%), Mirum Pharmaceuticals, Inc. (14.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short ArriVent BioPharma stock? Short selling AVBP is an investing strategy that aims to generate trading profit from ArriVent BioPharma as its price is falling. AVBP shares are trading down $1.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ArriVent BioPharma? A short squeeze for ArriVent BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AVBP, which in turn drives the price of the stock up even further. How often is ArriVent BioPharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVBP, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Kymera Therapeutics Short Interest Data Crinetics Pharmaceuticals Short Interest Data Viking Therapeutics Short Interest Data MoonLake Immunotherapeutics Short Interest Data Alvotech Short Interest Data HUTCHMED Short Interest Data Immunovant Short Interest Data Catalyst Pharmaceuticals Short Interest Data Organon & Co. Short Interest Data Mirum Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVBP) was last updated on 7/1/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.